Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers
British journal of surgery2014Vol. 101(4), pp. 321–338
Citations Over TimeTop 1% of 2014 papers
Koshi Kumagai, Ioannis Rouvelas, Jon A. Tsai, Daniela Mariosa, Fredrik Klevebro, Mats Lindblad, W Ye, Lars Lundell, Magnus Nilsson
Abstract
Neither NAC nor NACR for oesophageal carcinoma increases the risk of postoperative morbidity or perioperative mortality compared with surgery alone. There was no clear difference between NAC and NACR. Care should be taken with NACR in oesophageal SCC, where an increased risk of postoperative mortality and treatment-related mortality was apparent.
Related Papers
- → Accuracy of pleth variability index to predict fluid responsiveness in mechanically ventilated patients: a systematic review and meta-analysis(2015)63 cited
- → Effects of milk proteins on blood pressure: a meta-analysis of randomized control trials(2016)29 cited
- → Comparison of perioperative outcomes with or without routine chest tube drainage after video-assisted thoracoscopic pulmonary resection: A systematic review and meta-analysis(2022)10 cited
- → Controversies in the application of corticosteroids for pediatric septic shock treatment: a preferred reporting items for systematic reviews and meta-analysis-compliant updated meta-analysis(2020)5 cited
- → Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis(2021)3 cited